Sophia Genetics(SOPH) - 2022 Q4 - Annual Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (For the fiscal year ended December 31, 2022) Rue du Centre 172 CH-1025 Saint-Sulpice Switzerland +41 21 694 10 60 (Address of principal executive offices) Ross Muken OR o TRANSITION REPORT PURSUANT TO SECTION 13 O ...